Skip to content

Clinical trials

Phase 2 Liver Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20151
20161
20171
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genfit2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Conatus Pharmaceuticals Inc.1
European Foundation for Study of Chronic Liver Failure1
Galmed Research and Development, Ltd.1
Gilead Sciences1
Inventiva Pharma1
Vir Biotechnology, Inc.1
ZymoGenetics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases11
Fibrosis5
Non-alcoholic Fatty Liver Disease5
Liver Cirrhosis3
Acute-On-Chronic Liver Failure2
Digestive System Diseases2
Fatty Liver2
Ascites1
Cholangitis, Sclerosing1
Diabetes Mellitus1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.